Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy P Feldman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|November 29, 2007
Nebulized milrinone use in a pulmonary hypertensive crisisMitchell S Buckley, Jeremy P Feldman
Pharmacotherapy|June 26, 2010
Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adultsMitchell S Buckley, Jeremy P Feldman
Respiratory Medicine Case Reports|June 16, 2017
Blue after splenectomyTaaran Cariappa Ballachanda Subbaiah, Jeremy P Feldman
Drug, Healthcare and Patient Safety|June 25, 2011
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacyMitchell S Buckley, Robin L Staib, Laura M Wicks, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 11, 2005
Angiojet catheter-based thrombectomy in a neonate with postoperative pulmonary embolismJeremy P Feldman, Jeffrey A Feinstein, John J Lamberti, et al.
Journal of Critical Care|December 18, 2020
Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort studySophia Bonnin, John J Radosevich, Yong Gu Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 30, 2016
Transition from parenteral to oral treprostinil in pulmonary arterial hypertensionMurali M Chakinala, Jeremy P Feldman, Franz Rischard, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 9, 2011
Pharmacokinetic evaluation of ambrisentanMitchell S Buckley, Laura M Wicks, Robin L Staib, et al.
Pulmonary Circulation|March 19, 2021
Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension studyJeremy P Feldman, Mardi Gomberg-Maitland, Shelley M Shapiro, et al.
Pulmonary Circulation|August 29, 2022
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)Nicholas S Hill, Jeremy P Feldman, Sandeep Sahay, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|November 29, 2007
Nebulized milrinone use in a pulmonary hypertensive crisisMitchell S Buckley, Jeremy P Feldman
Pharmacotherapy|June 26, 2010
Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adultsMitchell S Buckley, Jeremy P Feldman
Respiratory Medicine Case Reports|June 16, 2017
Blue after splenectomyTaaran Cariappa Ballachanda Subbaiah, Jeremy P Feldman
Drug, Healthcare and Patient Safety|June 25, 2011
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacyMitchell S Buckley, Robin L Staib, Laura M Wicks, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 11, 2005
Angiojet catheter-based thrombectomy in a neonate with postoperative pulmonary embolismJeremy P Feldman, Jeffrey A Feinstein, John J Lamberti, et al.
Journal of Critical Care|December 18, 2020
Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort studySophia Bonnin, John J Radosevich, Yong Gu Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 30, 2016
Transition from parenteral to oral treprostinil in pulmonary arterial hypertensionMurali M Chakinala, Jeremy P Feldman, Franz Rischard, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 9, 2011
Pharmacokinetic evaluation of ambrisentanMitchell S Buckley, Laura M Wicks, Robin L Staib, et al.
Pulmonary Circulation|March 19, 2021
Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension studyJeremy P Feldman, Mardi Gomberg-Maitland, Shelley M Shapiro, et al.
Pulmonary Circulation|August 29, 2022
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)Nicholas S Hill, Jeremy P Feldman, Sandeep Sahay, et al.
Pageof 2